List of Excipients in API CYTARABINE
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing CYTARABINE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-223 | HYDROCHLORIC ACID |
| Sagent Pharmaceuticals | cytarabine | 25021-223 | SODIUM HYDROXIDE |
| Sagent Pharmaceuticals | cytarabine | 25021-223 | WATER |
| Sagent Pharmaceuticals | cytarabine | 25021-229 | HYDROCHLORIC ACID |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for CYTARABINE
Excipient focus: BENZYL ALCOHOL
CYTARABINE drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | cytarabine | 61703-304 |
| Meitheal Pharmaceuticals Inc | cytarabine | 71288-169 |
| >Company | >Ingredient | >NDC |
CYTARABINE drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-223 |
| Sagent Pharmaceuticals | cytarabine | 25021-229 |
| Hospira Inc | cytarabine | 61703-155 |
| Hospira Inc | cytarabine | 61703-303 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
CYTARABINE drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-223 |
| Sagent Pharmaceuticals | cytarabine | 25021-229 |
| Hospira Inc | cytarabine | 61703-155 |
| Hospira Inc | cytarabine | 61703-303 |
| >Company | >Ingredient | >NDC |
CYTARABINE drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
CYTARABINE drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-229 |
| Hospira Inc | cytarabine | 61703-303 |
| Hospira Inc | cytarabine | 61703-305 |
| Mylan Institutional LLC | cytarabine | 67457-454 |
| >Company | >Ingredient | >NDC |
CYTARABINE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-223 |
| Hospira Inc | cytarabine | 61703-155 |
| Hospira Inc | cytarabine | 61703-304 |
| Hospira Inc | cytarabine | 61703-319 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
CYTARABINE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-223 |
| Sagent Pharmaceuticals | cytarabine | 25021-229 |
| Hospira Inc | cytarabine | 61703-155 |
| Hospira Inc | cytarabine | 61703-303 |
| >Company | >Ingredient | >NDC |
CYTARABINE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
CYTARABINE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cytarabine | 25021-223 |
| Sagent Pharmaceuticals | cytarabine | 25021-229 |
| Hospira Inc | cytarabine | 61703-155 |
| Hospira Inc | cytarabine | 61703-303 |
| >Company | >Ingredient | >NDC |
CYTARABINE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional LLC | cytarabine | 67457-452 |
| Mylan Institutional LLC | cytarabine | 67457-454 |
| Mylan Institutional LLC | cytarabine | 67457-455 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
